The World Health Organization (WHO) has temporarily suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, the organization’s top official said on Monday.
WHO Director-General Tedros Adhanom Ghebreyesus said at a briefing that the organization’s trial of hydroxychloroquine, which has been touted by some as a promising preventative measure or therapeutic for COVID-19, would be put on hold for a safety review.
